Pharmaceutics formulation/chemistry manufacturing and controls consulting services for small molecules and/or biologics
Active Purchase Order Awarded Last action
- Contract number
- 75N95025P00442
- Awardee
-
Cellx, Inc. UEI L9PSTXCCZPD1
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $36,600
Award facts
- Opportunity
-
- Subject Matter Expert Consultant for Pharmaceutics / Formulation / Chemistry Manufacturing Control [CMC] Solicitation · 75N95025Q00057 · Posted Aug 8, 2025
- Contract value 100% obligated
- $36,600.00 Current and potential, with all options
- Completion date 52% complete
- Current and potential, with all options
- Funding agency
- National Institute of Neurological Disorders and Stroke National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- Total Small Business
- Competition
- Competed under SAP · 10 offers Simplified Acquisition
- Pricing
- Labor Hours
- Place of performance
- Potomac, MD 20854, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $20,600 | |
| Original award | $16,000 |
About this award
The National Institute of Neurological Disorders and Stroke awarded a purchase order to Cellx, Inc., a small business, for pharmaceutics formulation and chemistry manufacturing and controls consulting services with a ceiling value of $36,600.00 on September 29, 2025. The order exercises option year one under a total small business set-aside and is priced on a labor-hour basis. Work is performed in Potomac, Maryland, with performance concluding September 28, 2027. The consultant will provide subject matter expertise on drug development processes, regulatory risk evaluation, manufacturing strategy recommendations, and regulatory documentation support for small molecule and biologics programs, including NIH Blueprint Neurotherapeutics and the HEAL initiative. The procurement originated from a solicitation posted August 8, 2025, due August 22, 2025, issued under simplified acquisition procedures.
Quick answers
Who was awarded contract 75N95025P00442?
75N95025P00442 was awarded to Cellx, Inc. by National Institute on Drug Abuse (National Institutes of Health) on September 29, 2025.
How much is contract 75N95025P00442 worth?
The government has obligated $36,600 on 75N95025P00442.
Which agency awarded contract 75N95025P00442?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95025P00442, with funding from National Institute of Neurological Disorders and Stroke (National Institutes of Health).
Was contract 75N95025P00442 competed?
The extent of competition for 75N95025P00442 was competed under sap. The government received 10 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award